MEDPACE HOLDINGS, INC. <MEDP.O>: UBS RAISES TARGET PRICE TO $673 FROM $405

Reuters2026/09/30 12:38

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Aave’s Securities and GPU Expansion Puts AAVE Token Burn in Focus

CoinEdition•2026/09/30 12:45

U.S. final Q2 GDP data

Reuters•2026/09/30 12:42

MONGODB, INC. <MDB.O>: UBS CUTS TARGET PRICE TO $375 FROM $410

Reuters•2026/09/30 12:38

FactSet Research 4Q Adj Operating Margin 33% >FDS

Dow Jones•2026/09/30 11:09